0001104659-24-060263.txt : 20240513
0001104659-24-060263.hdr.sgml : 20240513
20240513085126
ACCESSION NUMBER: 0001104659-24-060263
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240510
FILED AS OF DATE: 20240513
DATE AS OF CHANGE: 20240513
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: BENTSUR RON
CENTRAL INDEX KEY: 0001251213
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-41264
FILM NUMBER: 24937074
MAIL ADDRESS:
STREET 1: 750 LEXINGTON AVE
STREET 2: 20TH FL
CITY: NEW YORK
STATE: NY
ZIP: 10022
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Nuvectis Pharma, Inc.
CENTRAL INDEX KEY: 0001875558
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 862405608
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1 BRIDGE PLAZA, SUITE 275
CITY: FORT LEE
STATE: NJ
ZIP: 07024
BUSINESS PHONE: 360-837-7232
MAIL ADDRESS:
STREET 1: 1 BRIDGE PLAZA, SUITE 275
CITY: FORT LEE
STATE: NJ
ZIP: 07024
4
1
tm2414233-3_4seq1.xml
OWNERSHIP DOCUMENT
X0508
4
2024-05-10
0
0001875558
Nuvectis Pharma, Inc.
NVCT
0001251213
BENTSUR RON
C/O NUVECTIS PHARMA, INC.
1 BRIDGE PLAZA, SUITE 275
FORT LEE
NJ
07024
1
1
1
0
Chairman & CEO
0
Common Stock
2024-05-10
4
P
0
2000
6.40
A
3244484
D
Reflects the weighted average purchase price. The range of prices for the shares purchased was $6.31 to $6.44. The reporting person effected multiple same-way open market purchase transactions on the same day at different prices through a trade order executed by a broker-dealer. The reporting person reported on a single line all such transactions that occurred within a one-dollar price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares purchased at each separate price
Includes 426,759 shares of restricted stock.
/s/ Ron Bentsur
2024-05-13